Prediction of Lymphopenia and Survival with Baseline Absolute Lymphocyte Count and Irradiated Dose to Immune Cells in Patients with Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

被引：0
|
作者：
Yang, G. [1 ]
Yoon, H. I. [2 ]
Lee, J. G. [1 ]
Kim, J. [1 ,3 ]
Kim, J. [1 ,3 ]
Kim, K. H. [1 ]
机构：
[1] Yonsei Univ, Heavy Ion Therapy Res Inst, Dept Radiat Oncol, Yonsei Canc Ctr,Coll Med, Seoul, South Korea
[2] Yonsei Univ, Dept Radiat Oncol, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Dept Radiat Oncol, Coll Med, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2170
引用
收藏
页码：E77 / E78
页数：2
相关论文
共 50 条
  • [21] Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer
    Kang, Byung-Hee
    Li, Xue
    Son, Jaeman
    Song, Changhoon
    Kang, Hyun-Cheol
    Kim, Hak Jae
    Wu, Hong-Gyun
    Lee, Joo Ho
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Modeling Survival Outcomes of Immune Checkpoint Inhibitors on Locally Advanced Non-Small Cell Lung Cancer Following Concurrent Chemoradiotherapy
    Huang, H. T.
    Hawkins, M. A.
    Fenwick, J. D.
    Nix, M. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E375 - E375
  • [23] Factors Affect the Survival Time after Recurrence in Stage III Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
    Hamamoto, Y.
    Kataoka, M.
    Semba, T.
    Uwatsu, K.
    Sugawara, Y.
    Inoue, T.
    Sakai, S.
    Takahashi, T.
    Aono, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S470 - S470
  • [24] The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy
    Yilmaz, Ufuk
    Ozdemir, Ozer
    Batum, Ozgur
    Ermin, Sinem
    INDIAN JOURNAL OF CANCER, 2018, 55 (03) : 276 - 281
  • [25] The effects of oral glutamine on clinical and survival outcomes of non-small cell lung cancer patients treated with chemoradiotherapy
    Gul, Kanyilmaz
    Mehmet, Koc
    Meryem, Aktan
    CLINICAL NUTRITION, 2017, 36 (04) : 1022 - 1028
  • [26] Cytokine Profiles of Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy with Regards to Radiation Pneumonitis Severity
    Jeong, Bae Kwon
    Kim, Jin Hyun
    Jung, Myeong Hee
    Kang, Ki Mun
    Lee, Yun Hee
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 10
  • [27] Facility case volume and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy
    Damhuis, R.
    Walraven, I.
    Widder, J.
    Senan, S.
    Belderbos, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S596 - S596
  • [28] IMPACT OF PRETRETMENT LEUKOCYTOSIS ON PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Topkan, Erkan
    Parlak, Cem
    Pehlivan, Berrin
    Ozyilkan, Ozgur
    Selek, Ugur
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S556 - S556
  • [29] Older patients with inoperable non-small cell lung cancer Long-term survival after concurrent chemoradiotherapy
    Semrau, Sabine
    Zettl, Heike
    Hildebrandt, Guido
    Klautke, Gunther
    Fietkau, Rainer
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (12) : 1125 - 1132
  • [30] IMPACT OF PRETRETMENT LEUKOCYTOSIS ON PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Topkan, Erkan
    Parlak, Cem
    Guler, Ozan C.
    Pehlivan, Berrin
    Selek, Ugur
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S412 - S412
12345